Spots Global Cancer Trial Database for Newton Study (NEW Dosing mainTenance Therapy Ovarian caNcer)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Newton Study (NEW Dosing mainTenance Therapy Ovarian caNcer)
Official Title: A Multicenter, Open-label Phase II Trial of a New Customized Dosing (RADAR Dosing) of Niraparib as Maintenance Therapy in Platinum Sensitive Ovarian, Fallopian Tube or Primary Peritoneal Recurrent Cancer Patients
Study ID: NCT03891576
Interventions
Study Description
Brief Summary: This study evaluates whether the adoption of the RADAR dosing strategy could further reduce treatment related toxicities improving the safety profile of niraparib.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: Yes
Locations
Charité - Universitätsmedizin Berlin, Berlin, , Germany
University Hospital Dresden, Dresde, , Germany
Kliniken Essen Mitte, Essen, , Germany
ASST degli Spedali Civili di Brescia, Brescia, , Italy
ASST di Lecco, Lecco, , Italy
Istituto Europeo di Oncologia, Milan, , Italy
Ospedale San Gerardo, Monza, , Italy
Istituto Oncologico Veneto (IOV), Padova, , Italy
AO Arcispedale Santa Maria Nuova, Reggio Emilia, , Italy
Policlinico Umberto I, Università di Roma "La Sapienza", Roma, , Italy
AO Ordine Mauriziano, Torino, , Italy
AOU Città della Salute e della Scienza di Torino - Ospedale Sant'Anna, Torino, , Italy
Contact Details
Name: Nicoletta Colombo, MD
Affiliation: Istituto Europeo di Oncologia (IEO) - Milan
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
